Just to be clear i dont think i have described them as a...

Just to be clear i dont think i have described them as a university study group. I think that was Akki.
The reason i still hold also after all these years is i agree they are working in some very interesting areas with great potential. I do see where the university comment comes from though as they seem to run the business with no urgency to get over the line and start earning cash from somewhere. I understand they need to work towards this goal and i understand the huge potential if they ever get there.


My concern that keeps my own personal glass half empty is that in the past they have seemed to :
1 Believe agreements, deals or collaborations were going well or about to be signed when reality showed this was not the case.

2 Name timelines for things to be achieved but never actually hit the dates. Not only that but not give a decisive reason or explanation when the touted date is reached, just go silent for 6 months to a year or more and hope we forget the promised result.

3 Change direction to the next best thing quite regularly. Makes me question if they have a promising technology ie cpp, but maybe dont have the clinical knowledge that others may posess in disease or cancer management so they can truly work out how best to apply the technology. I am not intending to disrespect the pyc staff and directors with this, they are obviously very talented and clever. It just seems they keep hitting brick walls that i would have thought they would have already known about. Ie why did we start looking at breast cancer for omomyc when apparently blood cancer is better target. Did that come as a surprise.

I definately hope they get there, but unfortunately all im wondering at the moment is " this should be interesting, they nominated a time frame and used the term WILL, so if they dont make this we then have another word to ignore in all future releases.

Ultimately i would just like yo see some urgency to get something on the table well before we need yet another cr on top of the 2 billion shares already on issue.